Formulary Changes 01/01/2026

Date: 10/01/25

Heritage Health (Medicaid):

Effective January 1, 2026, Freestyle Libre continuous glucose monitors will be the sole preferred product on the Nebraska Total Care Value-Add Formulary and will continue to require a prior authorization.  Dexcom G6 and Dexcom G7 Products will no longer be offered on the formulary and coverage exceptions may be approved when clinical criteria requirements are met. Please see our Pharmacy Policy section of the provider website for coverage criteria of continuous glucose monitors.